- Business
- Weihai Baihe Biology Technological Co., Ltd. engages in the research, development, production, and commercialization of nutritional foods, dietary supplements, and functional health products. Founded in 2005 and headquartered in Rongcheng, Weihai, Shandong Province, China, the company operates both as a contract development and manufacturing organization (CDMO/OEM/ODM) and as an owner-brand producer. The company offers an extensive product portfolio spanning multiple delivery formats and wellness categories, including softgels, hard capsules, tablets, functional gummies, powders, granules, oral liquids, drops, and nutritional beverages; specialized health formulations tailored for infants, children, seniors, pregnant and lactating women, and athletic populations; customized nutritional formulas and dietary supplements; pet nutritional food and wellness supplements; and turnkey contract manufacturing services encompassing formulation research, regulatory registration, lab testing, blending, and automated packaging. The company markets proprietary brands, including Biohek, Hongyangshen, Yunyangyan, Forzal, Zulixing, and Nengbeijian, while supplying customized private-label solutions to healthcare brands, pharmaceutical distributors, e-commerce retailers, and supermarket chains. Weihai Baihe Biology maintains operations across mainland China and exports products to more than 70 countries and regions throughout Europe, North America, Southeast Asia, and Australasia. In recent strategic and operational developments, the company has expanded its global manufacturing presence through cross-border investments, including an agreement to acquire a majority 56% stake in New Zealand-based health supplement manufacturer OraNutrition; continued the expansion and digital automation of its intelligent production plants to enhance high-volume daily output across dosage forms; diversified product lines deeper into specialized pet health nutrition and innovative functional delivery forms; and implemented corporate share repurchase programs to optimize its capital management.